Destiny Wealth Partners LLC Has $895,000 Position in HCA Healthcare, Inc. $HCA

Destiny Wealth Partners LLC increased its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.1% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 2,335 shares of the company’s stock after acquiring an additional 70 shares during the quarter. Destiny Wealth Partners LLC’s holdings in HCA Healthcare were worth $895,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its position in HCA Healthcare by 83.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its position in HCA Healthcare by 49.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after purchasing an additional 587,036 shares during the period. GAMMA Investing LLC increased its position in HCA Healthcare by 40,527.3% during the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. Nuveen LLC acquired a new stake in HCA Healthcare during the 1st quarter valued at approximately $569,217,000. Finally, Pacer Advisors Inc. boosted its holdings in shares of HCA Healthcare by 6,237.9% during the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock worth $466,815,000 after buying an additional 1,329,618 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on HCA. Royal Bank Of Canada cut their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Bank of America increased their price target on HCA Healthcare from $375.00 to $410.00 and gave the stock a “neutral” rating in a report on Wednesday, September 10th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. JPMorgan Chase & Co. increased their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Finally, Truist Financial increased their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $407.75.

HCA Healthcare Trading Down 0.4%

NYSE HCA opened at $414.75 on Friday. The firm has a market capitalization of $97.05 billion, a P/E ratio of 17.43, a PEG ratio of 1.31 and a beta of 1.41. The business has a fifty day simple moving average of $388.62 and a 200 day simple moving average of $368.12. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $420.98. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.